RBC Europe’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,000
| Closed | -$170K | – | 1199 |
|
|
2020
Q3 | $170K | Sell |
2,000
-670
| -25% | -$33.9K | 0.01% | 276 |
|
|
2020
Q2 | $94.6K | Hold |
2,670
| – | – | 0.01% | 343 |
|
|
2020
Q1 | $36K | Sell |
2,670
-670
| -20% | -$11.3K | ﹤0.01% | 442 |
|
|
2019
Q4 | $70.7K | Sell |
3,340
-5,830
| -64% | -$103K | 0.01% | 394 |
|
|
2019
Q3 | $122K | Hold |
9,170
| – | – | 0.01% | 301 |
|
|
2019
Q2 | $127K | Hold |
9,170
| – | – | 0.01% | 310 |
|
|
2019
Q1 | $176K | Sell |
9,170
-4,150
| -31% | -$66.9K | 0.02% | 252 |
|
|
2018
Q4 | $190K | Buy |
13,320
+7,046
| +112% | +$140K | 0.02% | 228 |
|
|
2018
Q3 | $131K | Buy |
+6,274
| New | +$149K | 0.01% | 312 |
|
|
2017
Q4 | – | Sell |
-240
| Closed | -$3.35K | – | 1166 |
|
|
2017
Q3 | $3.35K | Buy |
+240
| New | +$2.39K | ﹤0.01% | 1016 |
|
RBC Europe's IMMU Position: Q4 2020 in Review
RBC Europe sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,000 shares — an estimated $170K sold.
RBC Europe first reported a position in IMMU in Q3 2017 and held it in 10 quarters. The position peaked at $190K in Q4 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- RBC Europe reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- RBC Europe sold 2,000 Immunomedics Inc shares in Q4 2020, an estimated $170K.
- RBC Europe first reported a position in Immunomedics Inc in Q3 2017 and held it in 10 quarters.
- RBC Europe's Immunomedics Inc position peaked at $190K in Q4 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on RBC Europe's 13F filing for Q4 2020, filed 9 Nov 2023.